Historique
Auteur M. HICKMAN
Documents disponibles écrits par cet auteur (123)
Ajouter le résultat à votre sélection Affiner la rechercheNouveauté
J. M. KESTEN ; R. AYRES ; J. NEALE ; J. CLARK ; P. VICKERMAN ; M. HICKMAN ; S. REDWOOD | 2017
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : PériodiqueBackground: It is recommended that needle and syringe programmes (NSP) distribute low dead space syringes (LDSS) to reduce blood-borne virus transmission. We explored the acceptability of detachable LDSS among people who inject drugs (PWID) and [...]
R. MELOTTI ; J. HERON ; M. HICKMAN ; J. MACLEOD ; R. ARAYA ; G. LEWIS | 2011
Dans Pediatrics (Vol.127, n°4, April 2011) Article : PériodiqueObjective: To examine the association between use of alcohol and cigarettes among adolescents and their early socioeconomic background. Methods: Members of a longitudinal birth cohort (Avon Longitudinal Study of Parents and Children [ALSPAC], Un[...]
A. I. STIBY ; M. HICKMAN ; M. R. MUNAFO ; J. HERON ; V. L. YIP ; J. MACLEOD | 2015
Dans Addiction (Vol.110, n°4, April 2015) Article : PériodiqueAims: To investigate the relationship between cannabis and tobacco use by age 15 and subsequent educational outcomes. Design: Birth cohort study. Setting: England. Participants: The sample was drawn from the Avon Longitudinal Study of Parents[...]
C. BHARAT ; P. WEBB ; Z. WILKINSON ; R. McKETIN ; J. GREBELY ; M. FARRELL ; A. HOLLAND ; M. HICKMAN ; L. T. TRAN ; B. CLARK ; A. PEACOCK ; S. DARKE ; J. H. LI ; L. DEGENHARDT | 2023
Dans Addiction (Vol.118, n°9, September 2023) Article : PériodiqueBACKGROUND AND AIMS: Studies often rely upon self-report and biological testing methods for measuring illicit drug use, although evidence for their agreement is limited to specific populations and self-report instruments. We aimed to examine com[...]
C. ACEIJAS ; E. OPPENHEIMER ; G. V. STIMSON ; R. E. ASHCRAFT ; S. MATIC ; M. HICKMAN | 2006
PériodiqueObjective: To describe and estimate the availability of antiretroviral treatment (ART) to injecting drug users (IDUs) in developing and transitional countries. Methods: Literature review of grey and published literature and key informants' commu[...]
C. ANGUS ; R. PRYCE ; J. HOLMES ; F. DE VOCHT ; M. HICKMAN ; P. MEIER ; A. BRENNAN ; D. GILLESPIE | 2020
Dans Addiction (Vol.115, n°12, December 2020) Article : PériodiqueBACKGROUND AND AIMS: When measuring inequalities in health, public health and addiction research has tended to focus on differences in average life-span between socio-economic groups. This does not account for the extent to which age of death va[...]
ENGLISH : BACKGROUND: The UK heroin market is the biggest in Europe and approximately 70% of heroin deaths are due to fatal poisoning. Methadone treatment for heroin addiction in the UK, the 'British system', is unique as it is largely provide[...]
J. HAWKINS ; L. A. HINES ; C. BONELL ; M. HICKMAN ; L. ADARA ; J. TOWNSON ; R. CANNINGS-JOHN ; L. MOORE ; J. WHITE | 2025
Dans British Journal of Psychiatry (Vol.226, n°1, January 2025) Article : PériodiqueBACKGROUND: 'Inhalants' have been associated with poorer mental health in adolescence, but little is known of associations with specific types of inhalants. AIMS: We aimed to investigate associations of using volatile substances, nitrous oxide a[...]
L. A. HINES ; A. TRICKEY ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; L. DEGENHARDT ; S. COLLEDGE ; M. HICKMAN ; J. GREBELY ; E. B. CUNNINGHAM ; J. STONE ; K. DUMCHEV ; P. GRIFFITHS ; P. VICKERMAN ; R. P. MATTICK ; M. LYNSKEY | 2020
Dans Lancet Global Health (The) (Vol.8, n°1, January 2020) Article : PériodiqueBACKGROUND: Globally, an estimated 15.6 million people inject drugs. We aimed to investigate global variation in the age profile of people who inject drugs (PWID), identify country-level factors associated with age of PWID, and assess the associ[...]![Better data, better policy and better lives: a call for improved drug monitoring and concerted responses [Editorial]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_82705.webp)
C. M. COMISKEY ; A. L. BRETTEVILLE-JENSEN ; H. BERGERON ; G. BUHRINGER ; P. DARGAN ; M. DAVOLI ; F. FAGGIANO ; G. FISCHER ; F. RODRIGUEZ DE FONSECA ; H. GARRETSEN ; M. HICKMAN ; D. J. KORF ; K. KRAJEWSKI ; L. PAOLI ; R. SPANAGEL | 2020
Dans Addiction (Vol.115, n°2, February 2020) Article : PériodiqueWith the breadth of new psychoactive substances and international policy changes, an analysis of specific responses in all areas of drug supply and demand is beyond the resources of a single country. The Scientific Committee of the European Moni[...]
L. DEGENHARDT ; B. CLARK ; G. MACPHERSON ; O. LEPPAN ; S. NIELSEN ; E. ZAHRA ; B. LARANCE ; J. KIMBER ; D. MARTINO-BURKE ; M. HICKMAN ; M. FARRELL | 2023
Dans Lancet Psychiatry (The) (Vol.10, n°6, June 2023) Article : PériodiqueBackground: Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and buprenorphine are [...]
P. VICKERMAN ; N. MARTIN ; K. TURNER ; M. HICKMAN | 2012
Dans Addiction (Vol.107, n°11, November 2012) Article : PériodiqueAims: To investigate the impact of scaling-up opiate substitution therapy (OST) and high coverage needle and syringe programmes (100%NSP - obtaining more sterile syringes than you inject) on HCV prevalence among injecting drug users (IDUs). De[...]
ENGLISH : Aim : To estimate the prevalence of crack cocaine use in 12 London Boroughs (and London as a whole). Setting : Twelve London Boroughs, 2000-01. Methods : (1) Covariate capture-recapture techniques applied to three data sources of sub[...]
N. K. MARTIN ; M. HICKMAN ; S. J. HUTCHINSON ; D. J. GOLDBERG ; P. VICKERMAN | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : PériodiqueBACKGROUND: Interventions such as opiate substitution therapy (OST) and high-coverage needle and syringe programs (HCNSP) cannot substantially reduce hepatitis C virus (HCV) prevalence among people who inject drugs (PWID). HCV antiviral treatmen[...]
ENGLISH : Aims. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has produced methodological guidelines for national drug prevalence estimation. This paper pilots the methods to estimate prevalence for Great Britain and pro[...]
